Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering myocardial tissue.

Thomas Eschenhagen1, Wolfram H Zimmermann

  • 1Institute of Experimental and Clinical Pharmacology, University Medical Center, Hamburg-Eppendorf, Germany. t.eschenhagen@uke.uni-hamburg.de

Circulation Research
|December 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human induced pluripotent stem cell cardiomyocytes for risk stratification of patients with LQT syndrome - ready for practice?

Cardiovascular research·2026
Same author

Mechanical load inhibits cancer growth in mouse and human hearts.

Science (New York, N.Y.)·2026
Same author

Models of the human heart for biomedical research: Opportunities and challenges.

Physiological reports·2026
Same author

Simtuzumab Attenuates Loxl2-Mediated Extracellular Matrix Remodeling and Preserves Cardiac Function in <i>LMNA</i> Mutation-Induced Dilated Cardiomyopathy.

Circulation. Heart failure·2026
Same author

Activation of IRF3 in cardiomyocytes impairs mitochondrial oxidative function through PGC-1α inhibition and drives heart failure.

Nature communications·2026
Same author

Higher sensitivity to ouabain-induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes than human adult heart tissue despite similar Na<sup>+</sup>/K<sup>+</sup>-ATPase pump current amplitudes.

British journal of pharmacology·2026
Same journal

SBK2 Links Cardiac Stress Signaling to Mitochondrial Proteostasis.

Circulation research·2026
Same journal

Myeloid Piezo1 as a Brake on Efferocytosis and Cardiac Repair in the Infarcted Heart.

Circulation research·2026
Same journal

Targeting Late Na<sup>+</sup> Current: Too Late or Better Late Than Never?

Circulation research·2026
Same journal

HFpEF-Any: Human Single-Nuclear Transcriptomics Challenging the Translational Validity of Current HFpEF Models.

Circulation research·2026
Same journal

Myovascular Niche: The Role of Endothelial Cells in Skeletal Muscle Health and Disease.

Circulation research·2026
Same journal

Meet the First Authors.

Circulation research·2026
See all related articles

Tissue engineering aims to create artificial hearts, a complex goal still under development. Significant progress has been made in generating 3D heart muscle, offering potential for cardiac regeneration and experimental models.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Tissue Engineering

Background:

  • The creation of a bioartificial heart represents a significant challenge in regenerative medicine.
  • Early initiatives, like the LIFE initiative in 1999, generated both hope and skepticism.

Purpose of the Study:

  • To assess the progress and current state of tissue engineering in developing artificial heart constructs.
  • To evaluate the potential of engineered heart tissue for cardiac repair and as research models.

Main Methods:

  • Review of advancements in tissue engineering over the past decade.
  • Focus on the development of three-dimensional (3D) cardiac muscle equivalents.

Main Results:

  • While a fully functional bioartificial heart remains elusive, substantial progress has been achieved.

Related Experiment Videos

  • Development of 3D heart muscle constructs shows promise.

    • Conclusions:

    • The field of tissue engineering has made considerable strides towards creating functional cardiac tissues.
    • Engineered heart muscle holds potential for therapeutic applications in cardiac regeneration and as in vitro models.